baber/WOPTO huggingface dataset:
Patent SK-281879-B6 (SK)
Title: 4-aminotetrahydrobenzisoxazole or -isothiazole compounds, pharmaceutical preparation containing them and their use
Inventor: FALCH ERIK
IPC: A61K31/425
Filed: 1996-02-28
Abstract: The present invention relates to novel 4-aminotetrahydrobenzisoxazoles or 4-aminotetrahydrobenziothiazoles having gamma-aminobutanoic acid (GABA)-uptake inhibiting activity and thus useful in the treatment of analgesia, psychosis, convulsions, anxiety, epileptic disorders or muscular and movement disorders, such as spastic disorders or symptoms in Huntington's disease or Parkinson disease.
Patent SK-288540-B6 (SK)
Title: The additive from waste production of alumina for metallurgical applications and method for obtain thereof
Inventor: LADOMERSKY JURAJ
IPC: C21C1/08
Filed: 2010-08-11
Abstract: Described is an additive for metallurgical purposes containing up to 90 % wt. sludge from alumina production and min. 10 % wt. hydraulic binder and up to 1 % wt an activator or an additive in which 1 to 10 % wt. the sludge is replaced by waste containing metal or metal oxides, as well as the process of preparing the additive by mixing said materials and subsequently compressing the briquettes or other shaped products in a non-thermic manner.
Patent CZ-304054-B6 (CZ)
Title: Micro-encapsulated preparations containing two or more active components
Inventor: SZAMOSI JANOS
IPC: A01N37/22
Filed: 1999-08-13
Abstract: In the present invention, there is disclosed a method of encapsulating clomazone and a second biological agent comprising: (a) mixing (i) an aqueous phase, (ii) an emulsifier and (iii) a water-immiscible phase containing clomazone, the second biological agent, and at least one first polyfunctional compound; (b) forming a dispersion of water-immiscible droplets throughout the aqueous phase; and (c) adding at least one second polyfunctional compound into the dispersion and reacting the second polyfunctional compound(s) with the first polyfunctional compound(s) to form a polymer shell around the water-immiscible droplets wherein both clomazone and the second biological agent are in the form of water-immiscible droplets. Further provided is an agricultural composition comprising in capsules encapsulated clomazone and a second biological agent wherein the biological substances are co-micro-encapsulated.
Patent CZ-301648-B6 (CZ)
Title: Crank for hand-operated jack
Inventor: GAJDOS VOJTECH
IPC: B25G1/04
Filed: 2005-03-04
Abstract: In the present invention, there is disclosed a crank (1) for a hand-operated jack, said crank (1) having an arm (2) being coupled at its one end via a freewheeling clutch with a jack driving shaft while at its other end the arm (2) is provided with a handle (3). The handle (3) can swing on the arm (2) in three positions (A, B, C) û two working positions (A, B) and one transport positions (C). In the first working position (A) the handle (3) forms along with the arm (2) the crank (1), in the second working position (B) it forms a level of the length (L) being equal to the sum of the arm (2) length (L1) and the length (L2) of the handle (3), and in the transport position (C) the handle (3) abuts the arm (2). An arrestment mechanism of all the three positions (A, B, C) of the handle (3) is attached to the arm (2). The arrestment mechanism (11) consists of a segment provided with a location hole for a pin (13) representing an axis (4) of handle (3) tilting wherein said axis (4) is parallel to a plane (10) of the arm (2) turning. The handle (3) is formed by a pin (5) and a tubular casing (6) inserted thereon and axially pressed by a spring (7) into a recess (12) in the arrestment mechanism (11) wherein each position (A, B, C) of the handle (3) has its own recess (12).
Patent CZ-298687-B6 (CZ)
Title: Aqueous solution for animals exhibiting rehydrating activity and containing L-glutamine
Inventor: KLEIN PAVEL
IPC: A23K20/142
Filed: 2005-06-16
Abstract: The present invention relates to an aqueous solution for animals exhibiting rehydrating activity and containing L-glutamine for long-term administration to animals suffering from diarrheas, which aqueous solution contains in 1 liter 59 to 65 g of glucose, 2.9 to 3.4 g of sodium chloride, 1.3 to 1.7 g of potassium chloride, 2.2 to 2.8 g of sodium acid carbonate, 4.2 to 4.6 g of neutral sodium citrate, 6 to 12 g of L-glutamine and 15 to 25 g of 100% glycerol. In case of administering said rehydrating solution to animals to hyperhydrate them during their transportation, then 1 liter of the solution contains 20 to 30 g of glucose, 2 to 4 g of sodium chloride, 0.75 to 1.25 g of sodium hydrogen phosphate dodecahydrate, 1 to 2 g of potassium chloride, 1.5 to 3 g of sodium acid carbonate, 2 to 4 g of neutral sodium citrate, 1 to 5 g of L-glutamine, and 15 to 25 g of 100% glycerol.
Patent CZ-299082-B6 (CZ)
Title: Intervertebral disk prosthesis
Inventor: HORAK ZDENEK
IPC: A61F2/44
Filed: 2006-05-11
Abstract: In the present invention, there is disclosed an intervertebral disk prosthesis consisting of two rigid plates (1) disposed substantially one above another and an elastic damping core (2) inserted and glued between said rigid plates (1). Said elastic damping core (2) is provided with at least one projection (21) on each of its upper and lower surfaces and/or with at least one part fitting into at least one through hole (11) of the rigid plates (1) and/or into at least one internal depression (12) of the solid rigid plates (1). The prosthesis can be of identical height or of wedge-like form. The outer surfaces of the plates (1) with following outer surfaces of the damping core (2) projections (21) or that of the damping core (2) parts can form a substantially continuous surface. The through holes (11) of the plates (1) can be arranged symmetrically or asymmetrically relative to the prosthesis axis (5). Said elastic damping core (2a) can be made of a single material of single rigidity, optionally of at least two parts of different rigidities such as an outer ring (2b) and an inner liner (2c). The elastic damping core (2) can be arranged symmetrically or asymmetrically relative to the prosthesis axis (5) and/or to the rigid plate (1) through hole (11) or depression axis (7). The inner liner (2c) of the elastic damping core (2) can be situated symmetrically or asymmetrically relative to said elastic damping core (2) outer ring (2b).
Patent CZ-305673-B6 (CZ)
Title: Mechanically treated milk thistle fruit and a method of its treatment
Inventor: BUCHTA MARTIN
IPC: A23K10/30
Filed: 2007-08-02
Abstract: In the present invention, there is disclosed a mechanically treated milk thistle fruit that is particularly suitable for extraction of pharmaceutically active substances, the fruit comprising 80 to 90 percent of the initial weight of the non treated fruit, without external layers of the fruit, to thereby being enriched with internal sections of the milk thistle fruit having increased content of flavonolignans and oil relative to the average content thereof in the non treated fruit. A method of mechanical treatment of the milk thistle fruit comprises the following steps of: a) optionally predrying the milk thistle fruit; b) subjecting the preliminary dried milk thistle fruit to optional separation of mechanical impurities; c) mechanically removing 10 to 20 percent by weight of external layer from the initial weight of the milk thistle fruit at ambient temperature, at the most to a temperature of 35 degC, in order to increase the content of flavonolignans and oil in the milk thistle fruit internal section if compared with the average percentage content of flavonolignans and oil in the milk thistle fruit before this mechanical treatment.
Patent CZ-306707-B6 (CZ)
Title: A method of treatment of the surface of an aluminium heat exchanger
Inventor: MATSUI NORIZUMI
IPC: C23C28/00
Filed: 2014-03-24
Abstract: The method of treatment of the surface of the NB heat exchanger used for air conditioners for automobiles, which is capable of provide excellent corrosion resistance (resistance to white rust) and moisture resistance (resistance to blackening). The method includes: a) the step of exposing the NB heat exchanger to a chemical conversion when a film is formed on the surface by the chemical conversion, this treatment is carried out using a chemical conversion treatment agent comprising zircon and/or titanium in a total amount of 0.0005 to 0.5% by weight, vanadium in an amount of 0.001 to 0.1% by weight and has a pH of 2 to 6; b) the step of bringing the NB heat exchanger, having on its surface a film formed by the chemical conversion in step a), into contact with a hydrophilizing agent comprising a hydrophilic resin and a guanidine compound and/or its salt; c) the step of baking the NB heat exchanger which was exposed to the contact action in step b) when a hydrophilic film was created on its surface.
Patent CZ-305666-B6 (CZ)
Title: Process for preparing biochar-based formulation for plant growth support
Inventor: MAREK MIROSLAV
IPC: C12N1/14
Filed: 2014-08-15
Abstract: The process for preparing biochar-based formulation for plant growth support according to the present invention is based on application of biochar in combination with cultured microorganisms. Phytomass intended for the preparation of biochar is heated in an induction heating reactor to a temperature in the range of 300 to 600 degC for a period of 2 to 5 hours or by mans of magnetrons in combination with sight glasses of sapphire glass for access of microwaves to the phytomass at a temperature in the range of 800 to 1400 degC. The thus obtained biochar is then enriched with the addition of biomass-cultured microorganisms and/or mycorrhiza fungi and/or fertilizers and/or hydrocolloids. The biochar-based formulation of the present invention is used particularly in agriculture and forestry practice for the support of growth off higher plants.
Patent CZ-308221-B6 (CZ)
Title: Intermittent vacuum applicator
Inventor: KLOC KAREL
IPC: A61H37/00
Filed: 2019-10-30
Abstract: The intermittent vacuum applicator comprises a strengthened roller (2) with a closed bottom (7) at one end and an annulus (8) at the other, opposite end. The bottom (7) of the strengthened roller (2) has at least one outlet (3). On the strength wall roller (2) there is tightly fitted with a flexible sleeve (1) which has at one end a resilient edge (6) extending to the bottom of the sleeve (7) and connected at the other end to a sealing sleeve (4) which has a diffuser (5) which fits tightly on the annulus (8).
Patent SK-286098-B6 (SK)
Title: Mechanical anticorrosive material used for protection of product conduit
Inventor: KISS STEFAN
IPC: C04B28/00
Filed: 2003-05-30
Abstract: Powder cement composites are described, which are used as filling bound between two geotextiles made from synthetic fibres, and which form a sandwich type bandage for mechanical and anticorrosive protection of conduits. The powder cement composite is a two- or three-component mixture comprising Portland cement and calcium-magnesium-aluminosilicate admixture with possible partial replacement of the admixture by a powder organic material. The cement content changes within the range from 51 to 99 % by weight. The admixture content of natural or artificial origin changes within the range from 49 to 1 % by weight, where up to 14 % by weight of the admixtures, relating to 100 % by weight of cement composite content, can be replaced by an organic powder admixture.
Patent SK-285498-B6 (SK)
Title: Vulcanizing agent and process for production thereof
Inventor: MACHO VENDELIN
IPC: C08C19/00
Filed: 2002-05-20
Abstract: It is described a vulcanizing agent for the sulfur vulcanization of rubber mixes, which is the result of the addition to polyreactions of sulfur in the presence of at least one unsaturated C12-C22 aliphatic carboxyl acid with 1 to 4 double bonds in a molecule and/or their esters with C1-C4-alkanoles or C3-C18-alkenoles, eventually mixtures of monoene to polyene and an auxiliary substance or substances, whereby the total content of sulfur in the agent is 75 to 96 % by weight and a process for production thereof.
Patent CZ-294135-B6 (CZ)
Title: Use of coolant for cooling magnesium-based components
Inventor: BRINCK CARMEN
IPC: C23F11/12
Filed: 1998-10-07
Abstract: In the present invention, there is disclosed the use of a cooling liquid containing a) 0.005 to 0.5 percent by weight of tolyl-triazole, b) 0.005 to 0.5 percent by weight of benzotriazole, c) 0.005 to 10 percent by weight of at least one corrosion inhibitor being selected from the group consisting of aliphatic carboxylic acids with branched chain having 6 to 11 carbon atoms and alkanolamine phosphates, d) 70 to 99,985 percent by weight of water soluble liquid alcohol with a boiling point above 100 degC at atmospheric pressure, whereby the balance to 100 percent by weight is water, bases and/or other active substances. The invented cooling liquid is intended for use in cooling units made of magnesium and/or magnesium alloys.
Patent CZ-299773-B6 (CZ)
Title: Encryption communication system and corresponding apparatus
Inventor: SCHEIDT EDWARD M
IPC: G09C1/00
Filed: 1998-07-02
Abstract: In the present invention, there is disclosed an encryption communication system, which includes an origination space (2), a communications channel (6), and a destination space (4) associated with the origination space (2) via the communications channel (6). The origination space (2) includes an encryption engine (12) for generating an output symbol Oit based on an input symbol Iit and means for receiving an encrypt key (10), an encrypt text/key relation (14), and the input symbol. The destination space (4) includes a decryption engine (18) for generating a decrypted symbol I'it based on the output symbol received from the origination space (2) via the communications channel (6) and means for receiving a decrypt key (20) and a decrypt text/key relation. The encrypt text/key relation (14) controls the encryption engine such that Oit = {alpha}iN(t) + {pi}iN[{alpha}iN-1(t) + {pi}iN-1[ {alpha}iN-2(t) +...+ {pi}i2[{alpha}i1(t) + {pi}i1[Iit + {alpha}i0(t)]]...]], mod W, where {alpha}iN, {alpha}iN-1, ..., {alpha}i1, {alpha}i0 are N+1 additive transformations defined by the encrypt key (10), where {pi}iN, {pi}iN-1, ..., {pi}i2, {pi}i0 are N permutations defined by the encrypt key (10), and where W represents the number of possibilities for each permutation defined by the encrypt key (10). The decrypt text/key relation (14) controls the decryption engine (18) such that I'it = {pi}i1e-1[{pi}i2e-1[{pi}i3e-1 ...[{pi}iN-1e-1[{pi}Ne-1[Oit- {alpha}'iN(t)]- {alpha}'iN-1(t)]-...-{alpha}'i3(t)]- {alpha}'i2(t)]- {alpha}'i1(t)]- {alpha}'i0(t), mod W, where {pi}iie-1> is defined by the decrypt key (20) as the inverse of the permutation {pi}ii, where {alpha}'iN, {alpha}'iN-1, ..., {alpha}'i1, {alpha}'i0 are N+1 additive transformations defined by the decrypt key (20), and where W represents the number of possibilities for each inverse permutation defined by the decrypt key (20).
Patent CZ-295594-B6 (CZ)
Title: Use of anticonvulsant derivatives for preparing a medicament useful in the treatment of bulimia nervosa
Inventor: HOOPES SCOTT P
IPC: C07H11/00
Filed: 2000-01-31
Abstract: In the present invention, there is described the use of anticonvulsant derivatives of the general formula I, in which X represents CHi2 or an oxygen  atom, for the preparation of a medicament intended for treating bulimia nervosa.
Patent SK-287506-B6 (SK)
Title: Pyridoindole derivatives with antioxidant properties, process for their preparation and their use in medical praxis and pharmaceutical preparations
Inventor: STOLC SVORAD
IPC: C07D471/04
Filed: 2003-10-23
Abstract: Disclosed are 1,2,3,4,4a,9b-hexahydro-1H-pyrido[4,3-b]indole derivatives of general formula (III), wherein the hydrogen atoms in positions 4a and 9b are in cis configuration, process for their preparation, their use for the manufacture of medicaments and pharmacological preparations containing them. The derivatives in question have antioxidant properties and have none or only low alpha-adrenolytic activity and therefore is suggested their use for the manufacture of medicaments for the prevention and the treatment of neurodegenerative diseases in which oxidative stress or insufficient protection by natural endogenous antioxidant mechanisms play significant role.
Patent SK-287677-B6 (SK)
Inventor: HOFMANN HANS
IPC: C12P17/16
Filed: 1999-02-17
Abstract: The invention relates to a crystal form of epothilone B called the modification A and a crystal form of epothilone B called the modification B, a pharmaceutical composition containing such crystal forms and their use.
Patent CH-697394-B8 (CH)
Title: Verfahren zur Herstellung synthetischer Taxane.
Inventor: TANG DINGNING
IPC: C01F17/00
Filed: 2005-01-17
Abstract: Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung synthetischer Taxane, bei dem man die 7-OH-Gruppe mit Lanthanoidverbindungen schützt. Seine Vorteile sind ein einfaches Verfahren und eine feste und zuverlässige Bindung. Weiterhin wird bei dem anschliessenden Verfahren in der 7-Stellung kein Acylat gebildet, und die Hydrolyse der 2´-Estergruppen in den acylierten Produkten wird leicht steuerbar. In den Verfahren zur Herstellung synthetischer Taxane wird in der vorliegenden Erfindung als Acylierungsmedium Tetrahydrafuran verwendet, wodurch man nicht nur die gleichen Wirkungen wie mit Pyridin erzielt, sondern auch den Geruch vermeidet, so dass das Problem der extrem hohen Anforderungen an die Produktionsstätte gelöst wird. Die vorliegende Erfindung kann nicht nur zur Herstellung halbsynthetischer Taxane unter Verwendung von natürlichen Taxanen als Rohmaterial verwendet werden, sondern auch zur Herstellung von vollsynthetischen Taxanen.
Patent EP-1971338-B8 (EP)
Inventor: WEDGE STEPHEN ROBERT
IPC: A61P35/00
Filed: 2006-12-19
Granted: 2011-09-21
Abstract: The present invention relates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation, particularly a method for the treatment of a cancer, particularly a cancer involving a solid tumour, which comprises the administration of ZD6474 in combination with pemetrexed; to a pharmaceutical composition comprising ZD6474 and pemetrexed; to a combination product comprising ZD6474 and pemetrexed for use in a method of treatment of a human or animal body by therapy; to a kit comprising ZD6474 and pemetrexed; to the use of ZD6474 and pemetrexed in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation.
Patent BR-PI0616997-B8 (BR)
Inventor: ANDREAS EBERLE
IPC: A61M5/32
Filed: 2006-08-03
Abstract: A needle assembly (10; 210) for a prefilled injection syringe is described. A needle holder (12; 212) has a needle (14; 214) secured to it and is adapted to be secured to a syringe barrel of the injection syringe. A needle sheath (16; 216) has a distal end forming a releasable sterile seal with the needle holder (12; 212), and surrounds and shields the needle (14; 214). A needle seal (18; 218) surmounts the needle tip and is arranged at least in part in the proximal end of the needle sheath (16; 216) and closed off by a closure element (20; 220). A closure connection between the closure element (20; 220) and the needle sheath (16; 216) is configured as a non-releasable and sterile barrier (54; 254) produced by means of bonding or welding.
Patent BR-PI0923351-B8 (BR)
Title: implante dentário em múltiplas partes
Inventor: JÜRGEN MEHRHOF
IPC: A61C8/00
Filed: 2009-12-11
Abstract: implante dentário em múltiplas partes a invenção refere-se a um implante dentário em múltiplas partes, com pelo menos uma parte de implante proximal e uma parte de implante distal, que são para ser conectadas entre si, de modo que um sítio de conexão é obtido quando as duas partes de implante estão no estado conectado. um elemento de selagem anular é arranjado neste sítio de conexão e, no estado encaixado do implante dentário, é preso entre superficies de selagem mutuamente opostas, isto é, uma superficie de selagem da parte de implante proximal e uma superficie de selagem da parte de implante distal, de modo que o elemento de selagem tem uma parte de superficie externa que faz parte do contorno externo do implante dentário. as duas superficies de selagem inicialmente se aproximam entre si em uma direção orientada para fora, a partir de um eixo-geométrico longitudinal central do implante dentário. as superficies de selagem fundem-se em superficies externas do implante dentário no local onde, no contorno externo do implante de dente encaixado, uma parte de superficie formada pelo elemento de selagem em cada caso fica contígua a uma parte de superficie formada pela respectiva parte de implante. estas superficies externas movem-se para longe entre si, na direção orientada para fora.
Patent ES-2350672-B8 (ES)
Title: Modulador de fase basado en osciladores sincronizados.
Inventor: RAMIREZ TERAN FRANCO ARIEL
IPC: H03B5/12
Filed: 2010-09-24
Granted: 2011-09-27
Abstract: Modulador de fase basado en osciladores
sincronizados. 
     Un modulador de fase (20) diseñado para obtener
a su salida un margen de fase estable de 360º, que comprende: un
generador para inyectar (200) una señal a una frecuencia de entrada
\omega_{0}; un oscilador push-push que a su vez
comprende un primer oscilador (201) y un segundo oscilador (202)
igual al primero (201), operando ambos osciladores (201, 202) a
dicha misma frecuencia de entrada \omega_{0}, estando dichos
primer y segundo osciladores (201, 202) conectados entre sí mediante
una red de acoplo (203) diseñada para que las salidas de ambos
osciladores (201, 202) se encuentren desfasadas entre sí 180º, donde
dicho oscilador push-push comprende además una red
de combinación de potencia (204) diseñada para sumar la salida de
ambos osciladores (201, 202) y obtener una salida única (205) cuya
frecuencia de operación es el doble de dicha frecuencia de entrada
2\omega_{0}; y medios (207) para inyectar dicha señal de entrada
procedente del generador (200), desfasada 180º, simultáneamente a
cada uno de dichos primer y segundo osciladores (201, 202). El
modulador de fase (20) comprende una red de polarización y control
(206) configurada para proporcionar una pluralidad de tensiones de
control (V_{1}, V_{2}, V_{3} ...) a dichos   
     primer y segundo osciladores (201, 202),
habiendo tantos valores para las tensiones de control como número de
valores de fase necesarios para un determinado tipo de modulación en
fase, donde dichos valores de fase se ajustan mediante el ajuste de
al menos una de dichas tensiones de control.
Patent AU-2012307449-B8 (AU)
Title: Sulfonic acid salts of heterocyclylamide-substituted imidazoles
Inventor: SCHIFFER GUIDO
IPC: A61K31/4439
Filed: 2012-09-12
Granted: 2017-03-23
Abstract: The invention relates to sulfonic acid salts of heterocyclylamide-substituted imidazoles, and to solvates and hydrates thereof, to the use thereof for treating and/or preventing diseases, and to use thereof for producing drugs for treating and/or preventing diseases, in particular for use as antiviral agents, in particular against cytomegaloviruses.